Pharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrations

Antimicrob Agents Chemother. 2005 Apr;49(4):1629-32. doi: 10.1128/AAC.49.4.1629-1632.2005.

Abstract

The pharmacokinetics of tigecycline, when given as a 100-mg loading dose followed by 50 mg every 12 h, were determined in serum and blister fluid. The peak tigecycline concentration and half-life in serum were greater than those in blister fluid. Tigecycline penetrates into blister fluid well, with a mean penetration rate of 74%.

MeSH terms

  • Adult
  • Blister / metabolism*
  • Body Fluids / metabolism
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Minocycline / administration & dosage
  • Minocycline / analogs & derivatives*
  • Minocycline / blood*
  • Minocycline / pharmacokinetics*
  • Skin
  • Tigecycline

Substances

  • Tigecycline
  • Minocycline